One in 10 Pain Meds Make It Through Development Process
Only 1 in 10 potential new pain medications make it fully through the drug development process.
Pain
Spinal Anesthesia Tied to More Severe Pain After Hip Fracture Surgery
Severe pain is common after hip fracture surgery, and spinal anesthesia is associated with greater pain in the first 24 hours after surgery.
Short-Term Improvement in Chronic Pain for Oral Cannabinoids
Oral synthetic cannabinoid products with high THC-to-CBD ratios are associated with moderate short-term improvement in chronic pain.
Lidocaine Infusions Beneficial for Refractory Chronic Migraine
Lidocaine infusions seem beneficial for refractory chronic migraine.
Gabapentin May Cut Opioid Needs for Oral Mucositis Pain During RT
For patients receiving concurrent chemoradiotherapy for squamous cell carcinoma of the head and neck, higher doses of gabapentin are well tolerated and associated with delayed time to first opioid use for additional pain control during radiotherapy.
Psychological Interventions Could Improve Function of Patients With MUPS
Investigators from the All India Institute of Medical Sciences searched publication databases for studies published between 2010 and 2021 of interventions for patients presenting with Medically Unexplained Physical Symptoms.
Hispanic Patients Wait Longer When Presenting to ED With Chest Pain
Hispanic patients presenting to the emergency department with chest pain wait longer to be treated, admitted, or discharged.
During Pandemic, Growth of Clinicians With X-Waivers for Buprenorphine Prescribing Slowed
The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic, and support and mentorship are needed to facilitate obtaining a waiver.
Disparities in Chronic Pain Highly Prevalent Among Multiracial Groups in the US
The aim of the study was to evaluate the prevalence of chronic pain disparities among the major racial and ethnic groups in the US.
Ketamine Infusions Improve Symptoms of Depression and Pain
Patients with treatment-resistant major depressive disorder or bipolar disorder without psychotic symptoms received intravenous infusions of 0.5 mg/kg ketamine 3 times per week for 2 weeks.
- Loading...
Loading...
Next post in Depressive Disorder
Loading... 
Loading...